| Literature DB >> 24817896 |
Katja Boehm1, Holger Cramer2, Thomas Staroszynski3, Thomas Ostermann1.
Abstract
Background. Breast cancer is one of the most common types of cancer. However, only a few trials assess the effects of arts therapies. Material and Methods. We searched the Cochrane Central Register of Controlled Trials, PubMed, and Google Scholar from their start date to January 2012. We handsearched reference lists and contacted experts. All randomized controlled trials, quasi-randomized trials, and controlled clinical trials of art interventions in breast cancer patients were included. Data were extracted and risk of bias was assessed. Meta-analyses were performed using standardized mean differences. Results. Thirteen trials with a total of 606 patients were included. Arts therapies comprised music therapy interventions, various types of art therapy, and dance/movement therapies. The methodological quality ranged from poor to high quality with the majority scoring 3 of 4 points on the Jadad scale. Results suggest that arts therapies seem to positively affect patients' anxiety (standardized mean difference: -1.10; 95%, confidence interval: -1.40 to -0.80) but not depression or quality of life. No conclusion could be drawn regarding the effects of arts therapy on pain, functional assessment, coping, and mood states. Discussion. Our review indicates that arts interventions may have beneficial effects on anxiety in patients with breast cancer.Entities:
Year: 2014 PMID: 24817896 PMCID: PMC3955604 DOI: 10.1155/2014/103297
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flowchart of study selection process.
Characteristics of the included studies.
| First author | Year | Type of study | Type of arts therapy | Treatment duration | Type of control | Outcomes | Instruments |
|
|
|---|---|---|---|---|---|---|---|---|---|
| Binns-Turner | 2011 | RCT | Preoperational music | Pre-/intra-/postoperation (71–78 mins) | No music/usual care | Blood pressure, heart rate, anxiety, and pain | SAI, VAS | 15 | 15 |
|
| |||||||||
| Bozcuk | 2006 | Crossover CCT | Music during chemotherapy | 2 chemotherapy sessions | Session 1 served as control | QoL | EORTC QLQ C-30 | 18 | 18 (crossover) |
|
| |||||||||
| Bulfone | 2009 | RCT | Music therapy | 12 weeks, 15 mins each session | No music/usual care | Anxiety | STAI | 30 | 30 |
|
| |||||||||
| Dibbell-Hope | 2000 | RCT | Dance, movement therapy | 6 weeks, one session per week lasting 3 hrs each | Waiting list | Mood states, symptoms, body image, and social desirability | POMS, SCL-90-R, BWB, and MCSDS | 15 | 16 |
|
| |||||||||
| Hanser | 2006 | RCT | Music therapy | 3 for every 45 minutes | No music/usual care | QoL, Spiritual wellbeing, depression, heart rate, and blood pressure | FACT-G, FACIT-Sp HADS, and HADS | 18 | 22 |
|
| |||||||||
| Zhou | 2011 | RCT | Music therapy | Hospital stay (13.6 ± 2 days) + 2 chemotherapy periods (18.9 ± 7.1 days), 2 daily for 30 mins each | No music/usual care | Depression | ZSDS | 54 | 51 |
|
| |||||||||
| Li | 2011 | RCT | Music therapy | 2 per day, 30 min session for maximum of 32.5 days | No music/usual care | Anxiety | SAI | 54 | 51 |
|
| |||||||||
| Oester | 2006 | RCT | Art therapy | 5 weeks total, 1 session per week | No art therapy/usual care | Coping | CRI | 20 | 21 |
|
| |||||||||
| Puig | 2006 | RCT | Art therapies | 4 sessions over 4 weeks, 60 mins each | Waiting list | Mood states | POMS | 20 | 19 |
|
| |||||||||
| Sandel | 2005 | RCT | Dance, movement therapy | 12 weeks: 6 weeks 2 sessions/week, 6 weeks 1 session, 1 hr each | Waiting list | Functional assessment, QoL, shoulder range of motion, and body image | FACT-B, ROM, BIS, and SF-36 | 19 | 16 |
|
| |||||||||
| Svensk | 2009 | RCT | Art therapy | 60 min session/week for 5 weeks | No art therapy/usual care | Quality of life | EORTC, WHOQOL-BREF | 20 | 21 |
|
| |||||||||
| Stordahl | 2009 | CCT | Music-assisted relaxation | 4 sessions over 4 weeks, 60 mins each | Relaxation alone | Depression, mood states, and benefit finding | CES-D, POMS, BFS | 10 | 10 |
|
| |||||||||
| Thyme | 2009 | RCT | Art therapy | 5 weeks | No art therapy/usual care | Social behaviour, symptoms | SASB, SCL-90 | 20 | 21 |
Abbreviations: RCT: randomized controlled trial; CCT: controlled clinical trial; QoL: quality of life; SAI: Spielberger State Anxiety Scale; VAS: visual analog scale; EORTC QLQ C-30: quality of life of cancer patients; STAI: State Trait Anxiety Inventory; POMS: Profile of Mood States; SCL-90-R: Symptom Checklist 90 (Revised); BWB: Berscheid-Walster-Bohrnstedt Body Image Scale; MCSDS: Marlowe-Crowne Social Desirability Scale; FACT-G: Functional Assessment of Cancer Therapy—General; FACT-B: Functional Assessment of Cancer Therapy for patients with breast cancer; FACIT-Sp: Functional Assessment of Chronic Illness Therapy—Spiritual Well-being Scale; HADS: Hospital Anxiety and Depression Scale; ZSDS: Zung Self Rated Depression Scale; SAI: State Anxiety Inventory; CRI: Coping Response Inventory; ROM: range of motion; BIS: body image scale; SF-36: Short Form Health Survey; WHOQOL-BREF: World Health Organisation Quality of Life; CES-D: Center for Epidemiologic Studies Depression Scale; BFS: benefit finding scale; SASB: structural analysis of social behaviour, SCL-90: Symptom Checklist.
Figure 2Forest plot of arts therapies for breast cancer, outcome parameter: anxiety.
Figure 3Forest plot of arts therapies for breast cancer, outcome parameter: depression.
Figure 4Forest plot of arts therapies for breast cancer, outcome parameter: quality of life.
GRADE assessment.
| Quality assessment | Number of patients | Effect | Quality | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Art therapy | Control | Relative | Absolute | ||
| Anxiety (follow-up 0–28 weeks, assessed with 3× STAI, 1× HADS-anxiety) | ||||||||||||
| 4 | randomized trials | no serious risk of bias | Some inconsistency | no serious indirectness | no serious imprecision | None | 117 | 88 | RR −7.09 | — |
| CRITICAL |
|
| ||||||||||||
| Depression (follow-up 0–28 weeks, assessed with HADS, ZSDS, and CES-D) | ||||||||||||
| 3 | randomized trials | no serious risk of bias | Some inconsistency | no serious indirectness | no serious imprecision | None | 117 | 88 | RR −1.05 | — |
| CRITICAL |
|
| ||||||||||||
| Quality of life (follow-up 0–28 weeks, assessed with 2× EORTC, 1× FACTG) | ||||||||||||
| 3 | randomized trials | no serious risk of bias | Some inconsistency | no serious indirectness | no serious imprecision | none | 117 | 88 | RR 1.89 | — |
| IMPORTANT |